Financhill
Back

iShares US Pharmaceuticals ETF Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IHE is experiencing selling pressure, which indicates risk of future bearish movement.

iShares US Pharmaceuticals ETF Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 66.43 Sell
20-day SMA: 67.85 Sell
50-day SMA: 68.89 Sell
200-day SMA: 68.01 Sell
8-day EMA: 66.39 Sell
20-day EMA: 67.37 Sell
50-day EMA: 68.44 Sell
200-day EMA: 67.77 Sell

iShares US Pharmaceuticals ETF Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.86 Sell
Relative Strength Index (14 RSI): 32.33 Sell
Chaikin Money Flow: -37712 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.49 - 68.93) Sell
Bollinger Bands (100): (67.96 - 71.5) Sell

iShares US Pharmaceuticals ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for iShares US Pharmaceuticals ETF Stock

Is iShares US Pharmaceuticals ETF Stock a Buy?

IHE Technical Analysis vs Fundamental Analysis

Sell
24
iShares US Pharmaceuticals ETF (IHE) is a Sell

Is iShares US Pharmaceuticals ETF a Buy or a Sell?

iShares US Pharmaceuticals ETF Stock Info

Market Cap:
0
Price in USD:
65.71
Share Volume:
53.2K

iShares US Pharmaceuticals ETF 52-Week Range

52-Week High:
72.94
52-Week Low:
60.60
Sell
24
iShares US Pharmaceuticals ETF (IHE) is a Sell

iShares US Pharmaceuticals ETF Share Price Forecast

Is iShares US Pharmaceuticals ETF Stock a Buy?

Technical Analysis of iShares US Pharmaceuticals ETF

Should I short iShares US Pharmaceuticals ETF stock?

* iShares US Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.